Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2010
08/19/2010US20100210718 Synergistic anti-oxidant treatment for lipotoxicity and other metabolically related phenomena
08/19/2010US20100210717 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
08/19/2010US20100210711 Methods and Compositions for the Treatment of Sterile Inflammation
08/19/2010US20100210709 Methods of Treatment of Opioid Tolerance, Physical Dependence, Pain and Addiction With Inhibitors of Certain Growth Factor Receptors
08/19/2010US20100210694 New no-donor aspirin derivatives
08/19/2010US20100210692 Methods of treatment using sirt modulators and compositions containing sirt1 modulators
08/19/2010US20100210686 Therapeutic agents useful for treating pain
08/19/2010US20100210685 Novel Substituted Indoles
08/19/2010US20100210682 Repeated Dosing of TRPV1 Antagonists
08/19/2010US20100210666 Methods of using a g protein-coupled receptor to identify peptide yy (pyy) secretagogues and compounds useful in the treatment of conditions modulated by pyy
08/19/2010US20100210660 Heterocyclic FXR Binding Compounds
08/19/2010US20100210659 Pyrrolidine derivatives as nk3 receptor antagonists
08/19/2010US20100210646 2-morpholin-4-yl-pyrimidines as pi3k inhibitors
08/19/2010US20100210644 Chemical compounds
08/19/2010US20100210641 Organic Compounds
08/19/2010US20100210635 Renin inhibitors
08/19/2010US20100210631 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
08/19/2010US20100210630 Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase
08/19/2010US20100210625 Novel1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligands
08/19/2010US20100210620 Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers
08/19/2010US20100210615 Compositions and methods for enhancing corticosteroid delivery
08/19/2010US20100210614 Compositions and methods for enhancing corticosteroid delivery
08/19/2010US20100210610 Organic compounds
08/19/2010US20100210609 Free of medium chain glycerides; topical delivery to skin; vehicle comprising at least two penetration enhancers such as propylene glycol, diisopropyl adipate, dimethyl isosorbide, 1,2,6-hexanetriol, and benzyl alcohol, as well as solvents and emulsifiers
08/19/2010US20100210606 Methods and reagents for the treatment of inflammatory disorders
08/19/2010US20100210605 Compositions Comprising 5-Amino-2-Hydroxybenzoic Acid and a Reducing Sugar
08/19/2010US20100210604 Zwitterion solution for low-volume therapeutic delivery
08/19/2010US20100210598 Toll-like receptor modulators and treatment of diseases
08/19/2010US20100210593 Pyridine- and Pyrimidinecarboxamides as CXCR2 Modulators
08/19/2010US20100210572 Hydrolysate of crocin
08/19/2010US20100210556 Use of a peptide as a therapeutic agent
08/19/2010US20100210554 Therapeutic uses of gastrin- 1 and g- pen-grgdspca
08/19/2010US20100210539 Use of peptide ll-37 as a therapeutic agent
08/19/2010US20100210537 Use of a defensin peptide as a therapeutic agent
08/19/2010US20100210535 Therapeutic use of neuropeptide ei and acth 7-38 and compositions thereof
08/19/2010US20100210518 Peg-lipid conjugates for increasing the solubility of drug compounds
08/19/2010US20100209958 Method of treating arthritis and promoting growth of articular chondrocytes
08/19/2010US20100209536 Methods and Kits for Use in the Treatment and Prevention of Diseases or Conditions of the Immune System or Infectious Diseases
08/19/2010US20100209529 Pharmacologic-functioning water and usage of the same
08/19/2010US20100209520 Oral pharmaceutical preparation for colon-specific delivery
08/19/2010US20100209516 Triggered Drug Release Via Physiologically Responsive Polymers
08/19/2010US20100209514 Method of treating pain by administering 24 hour oral oploid formulations exhibiting rapid rate of initial rise of plasma drug level
08/19/2010US20100209508 Substituted Phenylphosphates as Mutual Prodrugs of Steroids and ß-Agonists for the Treatment of Title Pulmonary Inflammation and Bronchoconstriction
08/19/2010US20100209507 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
08/19/2010US20100209498 Pharmaceutical compositions of duloxetine
08/19/2010US20100209494 Liposomes and Uses Thereof
08/19/2010US20100209488 Protein kinase modulating compounds and methods for making and using them
08/19/2010US20100209487 Nicked or gapped nucleic acid molecules and uses thereof
08/19/2010US20100209483 Transdermal delivery of meptazinol
08/19/2010US20100209467 Tdf-related compounds and analogs thereof, analogs and bioactive fragments
08/19/2010US20100209459 Alkaloid formulations
08/19/2010US20100209442 Deglycosylated and desialidated long pentraxin ptx3
08/19/2010US20100209437 Anti-CD3 Antibody Fromulations
08/19/2010US20100209434 Antibody formulation
08/19/2010US20100209433 Methods for the diagnosis and for the treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
08/19/2010US20100209423 Contain an Fc part derived from human origin and do not bind complement factor C1q; for inflammatory and thrombotic disorders such as critical limb ischemia or peripheral arterial occlusive disease; atherosclerosis, thrombosis, restenosis, asthma, arthritis
08/19/2010US20100209413 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death
08/19/2010US20100209394 Mitogen activated protein kinase modulator
08/19/2010US20100209359 Medicated chewing gum
08/19/2010DE102009009245A1 Composition useful for prevention and treatment of viral infections, preferably influenza, conjunctivitis or cervicitis and secondary infections that are associated with it, comprises an agglutination inhibitor
08/19/2010CA2755935A1 Hetero ring derivative
08/19/2010CA2752623A1 Alkylamido compounds and uses thereof
08/19/2010CA2752269A1 Novel triazine derivative and pharmaceutical composition comprising the same
08/19/2010CA2752074A1 Toll-like receptor modulators and treatment of diseases
08/18/2010EP2218454A1 Pharmaceutical composition combining acemetacin, methocarbamol and diacerein, which can be used in the treatment of rheumatoid arthritis and related diseases
08/18/2010EP2217565A1 Compounds which modulate the cb2 receptor
08/18/2010EP2217257A2 A standardized plant extract, process for obtaining the same and uses thereof
08/18/2010EP2217250A2 Immunomodulating compounds and related compositions and methods
08/18/2010EP1951692B1 Oxazole and thiazole ppar modulator
08/18/2010EP1934203B1 3,4-dihydro-2H-benzo[1,4]oxazine and 3,4-dihydro-2H-benzo[1,4]thiazine COMPOUNDS AS ALPHA2C ADRENORECEPTOR AGONISTS
08/18/2010EP1723131B1 Crystalline polymorphs of a cxc-chemokine receptor ligand
08/18/2010EP1451174B1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
08/18/2010EP1411910B1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum
08/18/2010EP1400510B1 Cyclic diamine compounds having fused-ring groups
08/18/2010EP1320526B1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
08/18/2010CN1993352B Piperazine derivatives with CCR3 inhibiting activity
08/18/2010CN101809034A C3b antibodies and methods for the prevention and treatment of complement- associated disorders
08/18/2010CN101809020A Perharidines as CDK inhibitors
08/18/2010CN101809002A morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
08/18/2010CN101808991A Acyclic derivatives as modulators of chemokine receptor activity
08/18/2010CN101808651A polymer conjugate of steroid
08/18/2010CN101808643A Preparation for the treatment of equine laminitis
08/18/2010CN101805392A Anti-inflammatory antibacterial polypeptide capable of blocking combination of LPS and MD2
08/18/2010CN101805390A Tripterine derivate and use thereof
08/18/2010CN101805387A Methylprednisolone aceponate new crystal form and preparation method thereof
08/18/2010CN101805340A Beta-chain simulative and correlation method thereof
08/18/2010CN101805303A Substituted hydroxylamine derivatives with anti-inflammatory activity and preparation method and application thereof
08/18/2010CN101805290A Aminosulfonyl pyrazol compounds and applications thereof
08/18/2010CN101805285A Nicotinic acid-contained curcumin ester derivative and preparation method and application thereof
08/18/2010CN101804195A Medicinal simulation calculus bovis and manufacturing method thereof
08/18/2010CN101804190A Tongbi cream for relieving rigidity of muscles and promoting blood circulation and preparation method thereof
08/18/2010CN101804189A Drug for treating primary dysmenorrhea
08/18/2010CN101804164A Health-care wine with medlar, flax kernel and fructus cannabis
08/18/2010CN101804158A Paste for traumatic injuries
08/18/2010CN101804154A Health care wind prepared from campanumaea pilosula, barbary wolfberry fruit and rhizoma polygonatum
08/18/2010CN101804124A Chuangou rheumatism-dispersing medicated wine
08/18/2010CN101804106A Medicine cushion and medicine bag for treating diseases of whole body
08/18/2010CN101804098A Compound cornu cervi degelatinatum preparation as well as preparation method and application thereof
08/18/2010CN101804096A Method for extracting purified total alkaloid of strychnos nux-vomica and application thereof in pharmacy
08/18/2010CN101804093A Heat clearing antidote
1 ... 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 ... 1272